ISPUB.com / IJNW/7/1/9072
  • Author/Editor Login
  • Registration
  • Facebook
  • Google Plus

ISPUB.com

Internet
Scientific
Publications

  • Home
  • Journals
  • Latest Articles
  • Disclaimers
  • Article Submissions
  • Contact
  • Help
  • The Internet Journal of Nutrition and Wellness
  • Volume 7
  • Number 1

Original Article

Vitamins: Issues of definition and regulation

G Morgan

Keywords

cochrane collaboration, definition, regulation, vitamin

Citation

G Morgan. Vitamins: Issues of definition and regulation. The Internet Journal of Nutrition and Wellness. 2008 Volume 7 Number 1.

Abstract

The term vitamin is scientifically inaccurate and furthermore, there appears to be a need for a contemporary definition of a vitamin. In addition, there is powerful evidence that the intake of certain vitamin supplements confers an increased risk of premature mortality. A regulatory and licensing framework therefore appears to be required in the interests of public protection. The Cochrane Collaboration, an evidenced based organisation, might have a lead role in taking these important matters forward.

 

Introduction

The historical use of citrus fruits, a rich source of ascorbic acid, to alleviate scurvy on sea voyages provides a well known example that certain organic chemicals have vital importance to human health. Subsequent investigations into organic chemicals with putative vital importance to health erroneously suggested they belonged exclusively to the chemical amine family (1). The word vitamin, a hybrid of vital amine, is therefore a scientifically inaccurate term.

Vitamins exert a diverse array of effects upon human biochemical systems and if they are not consumed in sufficient amounts, then deficiency leading to compromised health or disease may occur (2). The vitamin system therefore provides an important public health nutrition mechanism to help improve the health of the population.

Vitamins may be either fat soluble or water soluble and the current classification runs alphabetically from A to E although in addition to this, there is also vitamin K. Other letters of the alphabet has been used in the vitamin system at various times. For example, although vitamin PP, niacin, has been renamed as vitamin B3 the term vitamin PP still appears in the research literature (3). Essential fatty acids, such as linoleic acid, have also been historically classified, albeit temporarily, as vitamin F (4) although it appears that numerous websites still make reference to products containing vitamin F (5,6).

It therefore appears that revisiting the alphabetically based vitamin classification would be helpful for reasons of both scientific clarity and product licensing. Furthermore, vitamins present several issues of both definition and regulation that deserve to be given further consideration.

Definition of a vitamin

There are variable definitions of a vitamin published in the literature. Perhaps one of the most comprehensive of these is presented in Table 1 (7). Although this definition is helpful, it is not entirely satisfactory. For example, 100% of the human requirement for vitamin D, secosteroids, may be met through synthesis in the skin following exposure to sunlight (8). This is at variance to the definition which requires that vitamins cannot be synthesised within the body. This example suggests that there is a need for an evidence-based contemporary consensus definition of a vitamin to be produced.

The absence of a contemporary consensus definition of a vitamin creates yet another difficulty. There is increasing interest in so called nutraceuticals, another hybrid term of nutrition and pharmaceutical, to improve human health (9,10). Nutraceuticals may be targeted to particular tissues for specific benefits, analogues to the pharmacological principle of drug targeting (11). As a related dimension, there is interest in using technological methods in food production to increase nutraceutical related health benefits (12) and perhaps some nutraceuticals may eventually satisfy a contemporary vitamin definition.

For example, salicylate is an organic chemical present in fruits and vegetables (13). There is an increasing evidence-base that human intake of dietary or pharmaceutical salicylate may help reduce the risk of cancer (14). Perhaps salicylate may be reclassified as vitamin S (15) and possibly acetylsalicylate, better known as aspirin, may counteract deficiency (16). Such possibilities are contingent upon further evidence on the benefits of salicylate to human health as well as the contemporary vitamin definition. It may be recognised, however, that the term vitamin S is already in the public domain (17).

Importance of a regulation system

There is powerful evidence, derived from meta-analyses of randomised controlled trials, that taking certain vitamin supplements increases the risk of premature mortality. A systematic review of randomised trials on vitamin supplements published by Cochrane Collaboration (18), an evidenced based organisation, found that people taking supplements of vitamin A, beta-carotene or vitamin E had increased premature mortality risks. However, there is no regulatory and licensing framework for vitamins (19) which contrasts with medicines in which there are organisations, such as the UK Medicines and Healthcare Products Regulatory Agency, who ensure that medicines work and are acceptably safe (20).

Given the potential harm associated with the excess use of some vitamins and also the extensive product range available to the general public, a regulatory and licensing framework would appear to be an important health protection development. Such a framework, however, would firstly need to work from a contemporary definition of a vitamin and also take into account wider range of context issues. This might include the revisiting the evidence on optimal intake levels, dietary patterns within the population and also the community use of vitamins. This last issue is most important and for example, one study has suggested that perhaps 40% of the U.S population use vitamins and mineral supplements weekly (21).

Table 1 : Definition of a vitamin

  1. An organic chemical required in small amounts for complete health and well-being of the organism

  2. Not utilised primarily to supply energy or as a source of structural tissue components

  3. Function to promote physiologic processes vital to continued existence

  4. Cannot be synthesised by the organism and must be supplied de novo

  5. Deficiency causes a well-defined disease that is prevented or cured by the appropriate vitamin

From : Young V.R, Newberne P.M. Vitamins and cancer prevention : Issues and dilemmas. Cancer 1981;47:1226-1240.

Conclusions

Adequate dietary intake of organic chemicals that are currently classified as vitamins are important to promote the health of the population (22), particularly in groups who may be predisposed to increasing risks of ill health or chronic disease such as the elderly population. Furthermore, the potential of vitamins to be beneficial in other contexts, such as the prevention and treatment of childhood cancer (23), has also been suggested and further research appears warranted. However, limitations to maximising the public health potential of vitamins include the absence of a contemporary definition and also the need for a regulation system to ensure appropriate intake. Evidenced-based approaches to taking these developments forward appear needed and there are examples in the literature of how new evidence has led to changed recommendations, such as hormone replacement therapy (24,25).

Perhaps the Cochrane Collaboration initially could be the organisation that might usefully help to progress these important matters with respect to vitamins. Furthermore, developments on vitamins need to be set within a wider context of nutritional interventions to maximise health, such as control of caloric intake (26).

Statement & acknowledgement

The author has no conflict of interest to declare and would like to thank Dr Goran Bjelakovic for comments on an earlier draft of this paper.

References

1. Rosenfield L. Vitamine - vitamin. The early years of discovery. Clin. Chem. 1997; 43(4): 680-5.
2. Fairfield KM, Fletcher RH. Vitamins for chronic disease prevention in adults: scientific review. JAMA. 2002; 287(23): 3116-26.
3. Shymans'kyi IO, Kuchmerovs'ka TM. Noncoenzyme function of vitamin PP and its biologically active derivatives: the current state of the problem. Ukr Biokhim Zh. 2007; 79(5): 59-71.
4. Thomasson HJ. A biological method for the assay of essential fatty acids (vitamin F). Acta Physiol. Pharmacol. Neerl. 1955; 4(1): 114.
5. http://www.anyvitamins.com/vitamin-f-fattyacids-info.htm accessed November 17th 2008
6. http://www.ovdb.com/articles/vitamin-f/ accessed November 17th 2008
7. Young VR, Newberne PM. Vitamins and cancer prevention : Issues and dilemmas. Cancer 1981; 47: 1226-1240.
8. Kimlin MG. Geographic location and vitamin D synthesis. Mol. Aspects Med. 2008;Aug 28. doi:10.1016/j.mam.2008.08.005.
9. Brower V. A nutraceutical a day may keep the doctor away. European Molecular Biology Organisation 2005; 8(6): 708-711.
10. Kalra EK. Nutraceutical - definition and introduction. AAPS Pharm. Sci. 2003; 5(2): e25. doi: 10.1208/ps050225.
11. Biesalski HK, Tinz J. Nutritargeting. Adv. Food Nutr. Res. 2008;54:179-217.
12. Davies KM. Genetic modification of plant metabolism for human health benefits. Mutat. Res. 2007;622(1-2):122-37.
13. Blacklock CJ, Lawrence JR, Wiles D, Malcolm EA, Gibson IH, Kelly CJ, Paterson JR. Salicylic acid in the serum of subjects not taking aspirin. Comparison of salicylic acid concentrations in the serum of vegetarians, non-vegetarians, and patients taking low dose aspirin. J. Clin. Pathol. 2001 Jul;54(7):553-5.
14. Morgan G.P. The potential contribution of aspirin to cancer control programmes. http://www.ecancermedicalscience.com/ accessed on November 18th 2008
15. Morgan GP. An aspirin a day… New Scientist 2007; February 7th: 36-39.
16. Morgan GP. Should aspirin be used to counteract salicylate deficiency?' Pharmacology and Toxicology 2003; 93(4): 153-5.
17. http://www.knowledgerush.com/kr/encyclopedia/Vitamin-S/ accessed November 18th 2008
18. Bjelakovic G, Nikolova D, Gluud LL, Simonetti RG, Gluud C. Antioxidant supplements for prevention of mortality in healthy participants and patients with various diseases. Cochrane Database Syst. Rev. 2008 Apr 16;(2):CD007176.
19. Rosenberg IH. Challenges and opportunities in the translation of the science of vitamins. Am. J. Clin. Nutr. 2007; 85(1): 325S-7S.
20. Collier J. New arrangements for the Medicines and Healthcare products Regulatory Agency. BMJ 2005; 330; 917.
21. Artz MB, Harnack LJ., Duval SJ, Armstrong C, Arnett DK, Luepker RV. Use of non-prescription medications for perceived cardiovascular health. Am. J. Prev. Med. 2006; 30(1): 78-81.
22. Fletcher RH, Fairfield KM. Vitamins for chronic disease prevention in adults: clinical applications. JAMA. 2002; 287(23): 3127-9.
23. Stallings VA. Childhood cancer and vitamins: prevention and treatment. Pediatr. Blood Cancer 2008 Feb; 50(2 Suppl): 442-4.
24. Nelson HD, Humphrey LL, Nygren P, Teutsch SM, Allan JD. Postmenopausal hormone replacement therapy. JAMA 2002; 288: 872-881.
25. Kumle M. Declining breast cancer incidence and decreased HRT use. Lancet 2008; 372: 608-610.
26. Roth GS, Ingram DK, Joseph JA. Nutritional interventions in aging and age-related disease. Ann. N. Y. Adad. Sci. 2007; 1114: 369-71.

Author Information

Gareth Morgan, FRSPH
National Service Framework for Older People Project Manager, Welsh Assembly Government

Download PDF

Your free access to ISPUB is funded by the following advertisements:

 

BACK TO TOP
  • Facebook
  • Google Plus

© 2013 Internet Scientific Publications, LLC. All rights reserved.    UBM Medica Network Privacy Policy